Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New laser camera could help surgeons see blood flow in real time

NCT ID NCT07558174

First seen May 01, 2026 · Last updated Jun 19, 2026 · Updated 10 times

Summary

This study is testing a new imaging device called Laser Speckle Contrast Imaging (LSCI) to monitor blood flow in the leg before, during, and after surgery to restore circulation. Researchers will enroll 30 people scheduled for leg revascularization. The goal is to see if LSCI is a feasible and reliable tool for real-time perfusion monitoring.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Leiden University Medical Center

    RECRUITING

    Leiden, South Holland, 2333ZA, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Laser Speckle Contrast Imaging device

What this could lead to

If successful, this could provide a new, non-invasive way for doctors to monitor blood flow during leg surgery, potentially improving outcomes.

What could go wrong

This is a small, early feasibility study with only 30 participants. The new imaging method may not prove better than current techniques, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

peripheral arterial disease peripheral vascular disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.